A subsequent prospective study of 46 dogs confirmed the increase in circulating anti-desmoglein-2 antibodies with canine ARVC, but they found similar increases in other cardiac conditions, bringing into question disease specificity of the biomarker [163]. The gene discussed is DSG2; the disease is arrhythmogenic right ventricular cardiomyopathy.